Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Health and Human Services Food and Drug Administration [Docket No. FDA-2010-N-0001]
 AGENCY: Food and Drug Administration, HHS.
 ACTION: Notice.
 SUMMARY: The Food and Drug Administration (FDA) is announcing a tentative schedule of forthcoming meetings of its public advisory committees for 2011. During 1991, at the request of the Commissioner of Food and Drugs (the Commissioner), the Institute of Medicine (the IOM) conducted a study of the use of FDA's advisory committees. In its final report, one of the IOM's recommendations was for the Agency to publish an annual tentative schedule of its meetings in the 
                        **Federal Register**
                        . This publication implements the IOM's recommendation.
 FOR FURTHER INFORMATION CONTACT: Teresa L. Hays, Advisory Committee Oversight and Management Staff (HF-4), Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, Rm. 5290, Silver Spring, MD 20993-0002, 301-796-8220.


SUPPLEMENTARY INFORMATION: The IOM, at the request of the Commissioner, undertook a study of the use of FDA's advisory committees. In its final report in 1992, one of the IOM's recommendations was for FDA to adopt a policy of publishing an advance yearly schedule of its upcoming public 
                    ( print page 80060)
                    advisory committee meetings in the 
                    **Federal Register**
                    ; FDA has implemented this recommendation. The annual publication of tentatively scheduled advisory committee meetings will provide both advisory committee members and the public with the opportunity, in advance, to schedule attendance at FDA's upcoming advisory committee meetings. Because the schedule is tentative, amendments to this notice will not be published in the 
                    **Federal Register**
                    . However, changes to the schedule will be posted on the FDA advisory committees' Internet site located at 
                    *http://www.fda.gov/​AdvisoryCommittees/​default.htm.*
                     FDA will continue to publish a 
                    **Federal Register**
                     notice 15 days in advance of each upcoming advisory committee meeting, to announce the meeting (21 CFR 14.20). The following list announces FDA's tentatively scheduled advisory committee meetings for 2011. Table 1
Committee name
Tentative date(s) of meeting(s)**OFFICE OF THE COMMISSIONER**Pediatric Advisory Committee
March 21, June 21-22, December 5-6.Risk Communication Advisory Committee
February 10-11, May 5-6, August 15-16, November 17-18.Science Board to the Food and Drug Administration
February 25, May 20, August 19, November 10.**CENTER FOR BIOLOGICS EVALUATION AND RESEARCH**Allergenic Products Advisory Committee
May 12.Blood Products Advisory Committee
April 28-29, August 3-4, December 1-2.Cellular, Tissue and Gene Therapies Advisory Committee
February 10, September 22-23.Transmissible Spongiform Encephalopathies Advisory Committee
Date(s), if needed, to be determined.Vaccines and Related Biological Products Advisory Committee
February 24-25, May 18-19, September 20-21, November 16-17.**CENTER FOR DRUG EVALUATION AND RESEARCH**Anesthetic and Life Support Drugs Advisory Committee
March 10.Anti-Infective Drugs Advisory Committee
April date(s), if needed, to be determined.Antiviral Drugs Advisory Committee
April 27-29.Arthritis Advisory Committee
March 15-16, May 3.Cardiovascular and Renal Drugs Advisory Committee
March 31, April 1, July 26-27, October 20-21, December 13-14.Dermatologic and Ophthalmic Drugs Advisory Committee
April 13.Drug Safety and Risk Management Advisory Committee
Date(s), if needed, to be determined.Endocrinologic and Metabolic Drugs Advisory Committee
March 24.Gastrointestinal Drugs Advisory Committee
January 12, March 8, May date(s), if needed, to be determined.Nonprescription Drugs Advisory Committee
February 23-24.Oncologic Drugs Advisory Committee
February 8-9, March 29-30, June 28-29, July 13-14, September 14-15, December 7-8.Peripheral and Central Nervous System Drugs Advisory Committee
January 20-21, March 10.Advisory Committee for Pharmaceutical Science and Clinical Pharmacology
March 2.Psychopharmacologic Drugs Advisory Committee
Date(s), if needed, to be determined.Pulmonary-Allergy Drugs Advisory Committee
March 8.Advisory Committee for Reproductive Health Drugs
March 4, April and May date(s), if needed, to be determined.**CENTER FOR DEVICES AND RADIOLOGICAL HEALTH****Medical Devices Advisory Committee (Comprised of 18 Panels)**Anesthesiology and Respiratory Therapy Devices Panel
April 15.Circulatory System Devices Panel
January 25-26, February 24-25, March 24-25, April 28-29, December 8-9.Clinical Chemistry and Clinical Toxicology Devices Panel
November 9.Dental Products Panel
April 12-13, September 8-9.Ear, Nose, and Throat Devices Panel
September 28-29.Gastroenterology-Urology Devices Panel
January 20-21, April 21-22, July 14-15, October 27-28.General and Plastic Surgery Devices Panel
February 24-25, May 12-13, August 11-12, November 17-18.General Hospital and Personal Use Devices Panel
July 29.Hematology and Pathology Devices Panel
March 24-25, June 9-10, September 15-16, December 15-16.Immunology Devices Panel
March 31, June 30, September 29, December 1.Medical Devices Dispute Resolution Panel
April 8.Microbiology Devices Panel
October 13.Molecular and Clinical Genetics Panel
March 3-4.Neurological Devices Panel
January 27-28, March 17.Obstetrics and Gynecology Devices Panel
May 19-20, September 22-23.Ophthalmic Devices Panel
February 18.Orthopedic and Rehabilitation Devices Panel
April 26-27, July 8.Radiological Devices Panel
June 17, October 27-28.National Mammography Quality Assurance Advisory Committee
May 6, August 9.Technical Electronic Product Radiation Safety Standards Committee
May 25.( print page 80061)**CENTER FOR FOOD SAFETY AND APPLIED NUTRITION**Food Advisory Committee
March 30-31.**CENTER FOR TOBACCO PRODUCTS**Tobacco Products Scientific Advisory Committee
January 10-11, March 17-18, May, July, September, and November date(s), if needed, to be determined.**CENTER FOR VETERINARY MEDICINE**Veterinary Medicine Advisory Committee
April 11, September 12.**NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH**Science Advisory Board
November 9-10.
 Dated: December 16, 2010. Jill Hartzler Warner, Acting Associate Commissioner for Special Medical Programs.


[FR Doc. 2010-31961 Filed 12-20-10; 8:45 am] BILLING CODE 4160-01-P